HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

J Schwarz Selected Research

N- (3- iodopropen- 1- yl)- 2- carbomethoxy- 3- (4- chlorophenyl)tropane

8/2004Comparison of alpha-dihydroergocryptine and levodopa monotherapy in Parkinson's disease: assessment of changes in DAT binding with [123I]IPT SPECT.
6/2000Reduced striatal dopamine transporters in idiopathic rapid eye movement sleep behaviour disorder. Comparison with Parkinson's disease and controls.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


J Schwarz Research Topics

Disease

14Parkinson Disease (Parkinson's Disease)
01/2017 - 01/2000
5Hemorrhage
06/2013 - 07/2008
5Parkinsonian Disorders (Parkinsonism)
05/2008 - 05/2000
4Inguinal Hernia (Direct Inguinal Hernia)
01/2019 - 08/2002
4Pain (Aches)
01/2019 - 12/2000
4Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
09/2012 - 01/2003
4Stomach Neoplasms (Stomach Cancer)
06/2011 - 05/2003
4Neuroblastoma
12/2006 - 01/2000
3Infections
01/2018 - 01/2003
3Chronic Pain
02/2012 - 08/2011
3Leukemia
02/2011 - 01/2003
2Neoplasms (Cancer)
01/2018 - 12/2001
2Osteoporosis
10/2016 - 05/2007
2Myeloproliferative Disorders (Myeloproliferative Disorder)
06/2013 - 05/2006
2Primary Myelofibrosis (Myelosclerosis)
06/2013 - 03/2001
2Essential Thrombocythemia
06/2013 - 05/2006
2Thrombocytosis (Thrombocythemia)
06/2013 - 05/2006
2Convalescence
10/2011 - 08/2011
2Portal Hypertension
02/2011 - 03/2001
2Chromosome Aberrations (Chromosome Abnormalities)
01/2010 - 01/2002
2B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia)
01/2010 - 01/2008
2Hepatolenticular Degeneration (Wilson's Disease)
05/2008 - 08/2006
2Neurodegenerative Diseases (Neurodegenerative Disease)
05/2008 - 10/2002
2Disease Progression
09/2007 - 06/2001
2Tremor (Tremors)
04/2007 - 05/2000
2Carcinoma (Carcinomatosis)
01/2004 - 05/2003
2Trisomy (Trisomies)
01/2002 - 06/2000
2Essential Tremor (Essential Tremors)
05/2000 - 05/2000
1Hyperemia
12/2021
1Crohn Disease (Crohn's Disease)
11/2021
1Abdominal Hernia (Abdominal Hernias)
02/2017
1Dyskinesias (Dyskinesia)
01/2017
1Insulin Resistance
09/2014
1Type 2 Diabetes Mellitus (MODY)
09/2014
1Endometrial Neoplasms (Endometrial Cancer)
07/2014
1Thrombosis (Thrombus)
06/2013
1Hemophilia A (Haemophilia)
01/2013
1Myelodysplastic Syndromes (Myelodysplastic Syndrome)
09/2012
1Aplastic Anemia (Anemia, Hypoplastic)
09/2012
1Seroma
08/2011
1Splenomegaly
02/2011
1Lichen Sclerosus et Atrophicus (Lichen Sclerosus)
01/2011
1Pruritus (Itching)
01/2011
1Vulvar Lichen Sclerosus
01/2011
1Ovarian Neoplasms (Ovarian Cancer)
10/2008
1Drug-Related Side Effects and Adverse Reactions
07/2008
1Hematologic Diseases (Blood Diseases)
07/2008
1Leukocytosis (Pleocytosis)
07/2008
1Anemia
07/2008

Drug/Important Bio-Agent (IBA)

6Dopamine Plasma Membrane Transport Proteins (Dopamine Transporter)IBA
05/2008 - 02/2000
5tetra-4-amidinophenoxypropane (TAPP)IBA
01/2019 - 08/2002
5Dopamine (Intropin)FDA LinkGeneric
04/2007 - 02/2000
3C-Reactive ProteinIBA
12/2021 - 01/2002
32- carbomethoxy- 8- (3- fluoropropyl)- 3- (4- iodophenyl)tropaneIBA
09/2006 - 05/2000
2Biomarkers (Surrogate Marker)IBA
12/2021 - 07/2006
2Levodopa (L Dopa)FDA LinkGeneric
01/2017 - 08/2004
2anagrelide (Agrylin)FDA LinkGeneric
06/2013 - 05/2006
2AntibodiesIBA
01/2013 - 01/2003
2Immunoglobulins (Immunoglobulin)IBA
01/2010 - 01/2002
2promyelocytic leukemia-retinoic acid receptor alpha fusion oncoproteinIBA
07/2008 - 07/2008
2Anti-Bacterial Agents (Antibiotics)IBA
07/2008 - 11/2001
2NeurotoxinsIBA
12/2006 - 01/2001
23- iodo- 2- hydroxy- 6- methoxy- N- ((1- ethyl- 2- pyrrolidinyl)methyl)benzamideIBA
09/2006 - 04/2002
2Pharmaceutical PreparationsIBA
09/2006 - 05/2006
2N- (3- iodopropen- 1- yl)- 2- carbomethoxy- 3- (4- chlorophenyl)tropaneIBA
08/2004 - 06/2000
2Neuroprotective AgentsIBA
08/2004 - 06/2001
1Arginine (L-Arginine)FDA Link
12/2021
1E-SelectinIBA
12/2021
1Vascular Cell Adhesion Molecule-1 (Vascular Cell Adhesion Molecule 1)IBA
12/2021
1Fatty Acids (Saturated Fatty Acids)IBA
11/2021
1Protons (Proton)IBA
01/2018
1Carbidopa (Lodosyn)FDA LinkGeneric
01/2017
1Dietary ProteinsIBA
09/2014
1Proteins (Proteins, Gene)FDA Link
09/2014
14- (4- dihexadecylaminostyryl)- N- methylpyridium (DiA)IBA
06/2013
1Factor VIII (Coagulation Factor VIII)IBA
01/2013
1Protein Isoforms (Isoforms)IBA
09/2012
1tetraethylpyrazine (TEP)IBA
02/2012
1Polypropylenes (Polypropylene)IBA
08/2011
1Hemoglobins (Hemoglobin)IBA
02/2011
1Aspirin (Acetylsalicylic Acid)FDA LinkGeneric
02/2011
1Clobetasol (Clobetasol Propionate)FDA LinkGeneric
01/2011
1Telomerase (Telomerase Reverse Transcriptase)IBA
01/2010
1Transcription Factors (Transcription Factor)IBA
10/2008
1Fibrinogen (Factor I)FDA Link
07/2008

Therapy/Procedure

16Therapeutics
01/2018 - 11/2001
4Lymph Node Excision (Lymph Node Dissection)
06/2011 - 05/2003
3Drug Therapy (Chemotherapy)
07/2014 - 08/2004
3Herniorrhaphy
10/2011 - 08/2002
2Sutures (Suture)
01/2019 - 09/2006
2Lasers (Laser)
01/2018 - 12/2000
2Radiotherapy
07/2014 - 08/2004
2Transjugular Intrahepatic Portasystemic Shunt
09/2006 - 03/2001
2Epidural Analgesia
11/2001 - 07/2001
1Minimally Invasive Surgical Procedures
02/2017
1Operative Surgical Procedures
02/2012
1Contraindications
02/2011
1Stem Cell Transplantation
02/2011
1Length of Stay
03/2009
1Transurethral Resection of Prostate (TURP)
03/2009